BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36747777)

  • 1. [WITHDRAWN] Hexokinase-1 mitochondrial dissociation and protein O-GlcNAcylation drive heart failure with preserved ejection fraction.
    Tatekoshi Y; Shapiro JS; Liu M; Bianco GM; Tatekoshi A; De Jesus A; Koleini N; Wasserstrom JA; Dillmann WH; Weinberg SE; Ardehali H
    Res Sq; 2023 Jan; ():. PubMed ID: 36747777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Supinoxin blocks Small Cell Lung Cancer Progression by Inhibiting Mitochondrial Respiration through the RNA Helicase DDX5.
    Das S; Russon MP; Zea MP; Xing Z; Torregrosa-Allen S; Cervantes HE; Harper HA; Elzey BD; Tran EJ
    Res Sq; 2024 Apr; ():. PubMed ID: 38699339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.
    Lam CS; Carson PE; Anand IS; Rector TS; Kuskowski M; Komajda M; McKelvie RS; McMurray JJ; Zile MR; Massie BM; Kitzman DW
    Circ Heart Fail; 2012 Sep; 5(5):571-8. PubMed ID: 22887722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, Preserved Ejection Fraction Heart Failure, and Left Ventricular Remodeling.
    Stencel J; Alai HR; Dhore-Patil A; Urina-Jassir D; Le Jemtel TH
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay Between Phosphorylation and O-GlcNAcylation of Sarcomeric Proteins in Ischemic Heart Failure.
    Mercier T; Bouvet M; Dubois-Deruy E; Dechaumes A; Beseme O; Richard V; Mulder P; Pinet F
    Front Endocrinol (Lausanne); 2018; 9():598. PubMed ID: 30344511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Bekfani T; Bekhite Elsaied M; Derlien S; Nisser J; Westermann M; Nietzsche S; Hamadanchi A; Fröb E; Westphal J; Haase D; Kretzschmar T; Schlattmann P; Smolenski UC; Lichtenauer M; Wernly B; Jirak P; Lehmann G; Möbius-Winkler S; Schulze PC
    Circ Heart Fail; 2020 Dec; 13(12):e007198. PubMed ID: 33302709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol therapy in patients with heart failure with preserved ejection fraction - Results from the Croatian heart failure (CRO-HF) registry.
    Domagoj M; Branka JZ; Jelena M; Davor M; Duska G
    Med Clin (Barc); 2019 Jan; 152(2):43-49. PubMed ID: 29678315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of exercise echocardiography in heart failure with preserved ejection fraction.
    Donal E
    J Ultrason; 2019; 19(76):43-44. PubMed ID: 31088009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction.
    Jiang J; Yang B; Sun Y; Jin J; Zhao Z; Chen S
    Front Cardiovasc Med; 2021; 8():829151. PubMed ID: 35141299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Failure With Preserved Ejection Fraction Expert Panel Report: Current Controversies and Implications for Clinical Trials.
    Parikh KS; Sharma K; Fiuzat M; Surks HK; George JT; Honarpour N; Depre C; Desvigne-Nickens P; Nkulikiyinka R; Lewis GD; Gomberg-Maitland M; O'Connor CM; Stockbridge N; Califf RM; Konstam MA; Januzzi JL; Solomon SD; Borlaug BA; Shah SJ; Redfield MM; Felker GM
    JACC Heart Fail; 2018 Aug; 6(8):619-632. PubMed ID: 30071950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry.
    Mert GÖ; Özlek B; Özlek E; Zencirkiran Ağuş H; Tekinalp M; Kahraman S; Çil C; Çelik O; Başaran Ö; Doğan V; Kaya BC; Rencüzoğulları İ; Ösken A; Bekar L; Çakır MO; Çelik Y; Sancar KM; Sevinç S; Biteker M; Mert KU
    Anatol J Cardiol; 2023 Sep; 27(9):539-548. PubMed ID: 37655737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction.
    Gurwitz JH; Magid DJ; Smith DH; Goldberg RJ; McManus DD; Allen LA; Saczynski JS; Thorp ML; Hsu G; Sung SH; Go AS
    Am J Med; 2013 May; 126(5):393-400. PubMed ID: 23499328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight Reduction for Obesity-Induced Heart Failure with Preserved Ejection Fraction.
    Ayinapudi K; Samson R; Le Jemtel TH; Marrouche NF; Oparil S
    Curr Hypertens Rep; 2020 Jul; 22(8):47. PubMed ID: 32621156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity.
    Dhore-Patil A; Thannoun T; Samson R; Le Jemtel TH
    Front Physiol; 2021; 12():785879. PubMed ID: 35242044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
    Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    Dassanayaka S; Brittian KR; Long BW; Higgins LA; Bradley JA; Audam TN; Jurkovic A; Gumpert AM; Harrison LT; Hartyánszky I; Perge P; Merkely B; Radovits T; Hanover JA; Jones SP
    PLoS One; 2020; 15(11):e0242250. PubMed ID: 33253217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic architecture of heart failure with preserved versus reduced ejection fraction.
    Joseph J; Liu C; Hui Q; Aragam K; Wang Z; Charest B; Huffman JE; Keaton JM; Edwards TL; Demissie S; Djousse L; Casas JP; Gaziano JM; Cho K; Wilson PWF; Phillips LS; ; O'Donnell CJ; Sun YV
    Nat Commun; 2022 Dec; 13(1):7753. PubMed ID: 36517512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
    Saito Y; Obokata M; Harada T; Kagami K; Wada N; Okumura Y; Ishii H
    Eur J Prev Cardiol; 2023 Jul; 30(9):902-911. PubMed ID: 37094815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of epicardial adipose tissue as a predictor of heart failure with preserved ejection fraction.
    Ateş K; Demir M
    Rev Assoc Med Bras (1992); 2022 Sep; 68(9):1178-1184. PubMed ID: 36228249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.